These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 617483)

  • 21. Hepatic morphologic changes following end-to-side portacaval shunt in dogs.
    Lanier VC; Buchanan RD; Foster JH
    Am Surg; 1968 Mar; 34(3):185-95. PubMed ID: 5638502
    [No Abstract]   [Full Text] [Related]  

  • 22. Some observations on the cause of the gastric hypersecretion following portacaval shunt.
    McPhedran NT; Bett HD; Stone RM; Goldberg M
    Bull Soc Int Chir; 1968; 27(4):286-90. PubMed ID: 5714998
    [No Abstract]   [Full Text] [Related]  

  • 23. Prolonged hypocholesteremic effect of portacaval transposition in dogs. An experimental study.
    Castellanos J; Toledo-Pereyra LH; Mittal VK; Guzman I; Lillehei RC
    Eur Surg Res; 1981; 13(6):438-43. PubMed ID: 7040084
    [No Abstract]   [Full Text] [Related]  

  • 24. Proceedings: Alterations in the pharmacokinetics of drugs by portocaval shunt.
    Gugler R; Lain P; Azarnoff DL
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R89. PubMed ID: 1143512
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
    Shurberg JL; Resnick RH; Koff RS; Ros E; Baum RA; Pallotta JA
    Gastroenterology; 1977 Feb; 72(2):301-4. PubMed ID: 830579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of portacaval shunt on gastric secretion in cirrhotic dogs].
    Storace R
    Chir Patol Sper; 1965; 13(5):178-82. PubMed ID: 5887290
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of different types of portal derivation on the blood cholesterol level in the rat].
    Castaing D; Mathé D; Gigou M; Bismuth H
    Gastroenterol Clin Biol; 1984 May; 8(5):487-8. PubMed ID: 6735067
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of type II familial hyperlipemia by portacaval shunt].
    Benichou J; Starzl TE
    Nouv Presse Med; 1977 Dec; 6(45):4206-7. PubMed ID: 618358
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical and experimental studies of changes in blood volume, water and electrolyte spaces following hepatic insufficiency and portacaval shunt.
    Henegar GC; Pollitt J; Riveron EM; Kukral JC
    Proc Inst Med Chic; 1969 Jul; 27(10):280. PubMed ID: 5355083
    [No Abstract]   [Full Text] [Related]  

  • 31. Excretion of sodium and water in dogs before and after portacaval shunt.
    Heer FW; Baldwin JN; Albo R; Silen W
    Surg Forum; 1965; 16():278-80. PubMed ID: 5835156
    [No Abstract]   [Full Text] [Related]  

  • 32. Peptic ulcer disease and gastric hypersecretion following portacaval shunt.
    Gudis S
    Mt Sinai J Med; 1976; 43(5):593-601. PubMed ID: 1086969
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of increased hepatic resistance on the metabolic efficiency of the liver following a side-to-side portacaval shunt.
    Reilly JW; Price JB; Sawada M; Davidson DB; Voorhees AB
    Surg Forum; 1968; 19():326-8. PubMed ID: 5718652
    [No Abstract]   [Full Text] [Related]  

  • 34. Anorexia and weight loss in the portacaval-shunted pig.
    Hickman R; Terblanche J
    Surgery; 1976 Nov; 80(5):569-74. PubMed ID: 1068535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Portacaval shunt and liver transplantation in treatment of familial hypercholesterolemia.
    Bilheimer DW
    Arteriosclerosis; 1989; 9(1 Suppl):I158-63. PubMed ID: 2643427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic blood flow in dog cirrhosis following portacaval transposition.
    Kreuzer W; Schenk WG
    Surg Forum; 1971; 22():349-51. PubMed ID: 5121398
    [No Abstract]   [Full Text] [Related]  

  • 37. Lack of gastrointestinal metabolism of propranolol in dogs after portacaval transposition.
    Lo MW; Effeney DJ; Pond SM; Silber BM; Riegelman S
    J Pharmacol Exp Ther; 1982 May; 221(2):512-5. PubMed ID: 7077541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The problem of hepatic hemodynamic changes following portacaval anastomosis (PCA).
    Mazziotti A; Cavallari A; Gozzetti G; Possati L
    Ann Surg; 1983 Dec; 198(6):797-8. PubMed ID: 6639182
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of increased outflow resistance on retrograde portal flow and hepatic metabolic efficiency following a side-to-side portacaval shunt.
    Reilly JW; Price JB; Sawada M; Davidson DB; Voorhees AB
    Surgery; 1969 Dec; 66(6):1026-33. PubMed ID: 5402529
    [No Abstract]   [Full Text] [Related]  

  • 40. The metabolic response of the liver to portacaval shunt.
    Smith GW; Mouzas GL
    Br J Surg; 1969 Aug; 56(8):627. PubMed ID: 5797767
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.